(Q37008634)

17 August 2017

1 reference

title

Phenotypes of chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

17 August 2017

0 references

author name string

Adam L Friedlander

1

1 reference

17 August 2017

David Lynch

2

1 reference

17 August 2017

Liesel A Dyar

3

1 reference

17 August 2017

Russell P Bowler

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

17 August 2017

1 reference

17 August 2017

4

1 reference

17 August 2017

355-384

1 reference

17 August 2017

4

1 reference

Global initiative for chronic obstructive lung diseases (GOLD): time to act.

17 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Prognostic factors in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

APACHE II predicts long-term survival in COPD patients admitted to a general medical ward

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Mortality after hospitalization for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Treatment implications on morbidity and mortality in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Nutrition in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Effects of exercise on amino acid metabolism in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Systemic effects in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

From muscle disuse to myopathy in COPD: potential contribution of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Antioxidant supplementation preserves antioxidant response in physical training and low antioxidant intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Minimal clinically important differences in COPD lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Chronic obstructive pulmonary disease: molecular and cellularmechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Functional impairment in COPD patients: the impact of anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

High prevalence of anxiety symptoms in hospitalized geriatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Surprisingly high prevalence of anxiety and depression in chronic breathing disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Risk of depression in patients with chronic obstructive pulmonary disease and its determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Anxiety and depression in COPD patients: The roles of gender and disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Current perspectives on management of co-morbid depression in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

A cognitive approach to panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The catastrophic misinterpretation of physiological distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Obstructive airway diseases in women exposed to biomass smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Asthma as a risk factor for COPD in a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Cryptogenic constrictive bronchiolitis. A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Raised enzyme markers of chronic inflammation in asymptomatic farmers' lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Diffuse panbronchiolitis. A disease of the transitional zone of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Chronic obstructive pulmonary disease mortality in six U.S. cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The natural history of chronic airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Lung function decline and outcomes in an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Lessons from the Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Bronchodilator response in the lung health study over 11 yrs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Genetics of asthma and COPD. Similar results for different phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Relationship of respiratory drives to dyspnea and exercise performance in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Breathing pattern and carbon dioxide retention in severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Health status measurement in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The 6-min walk distance: change over time and value as a predictor of survival in severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Peak exercise capacity estimated from incremental shuttle walking test in patients with COPD: a methodological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Development of a shuttle walking test of disability in patients with chronic airways obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Why does the lung hyperinflate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Human lung volumes and the mechanisms that set them

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Ventilatory limitations in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Diffusing capacity in the clinical assessment of chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Single-breath diffusing capacity of the lung for carbon monoxide: a predictor of PaO2, maximum work rate, and walking distance in patients with emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Evaluation and management of the patient with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Elevated pulmonary artery pressure. An independent predictor of mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Hemodynamic characterization of patients with severe emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Pulmonary hypertension associated with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

A quantification of the lung surface area in emphysema using computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

An automated method to assess the distribution of low attenuation areas on chest CT scans in chronic pulmonary emphysema patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Quantitation of emphysema by computed tomography using a "density mask" program and correlation with pulmonary function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Chronic obstructive pulmonary disease: evaluation with spirometrically controlled CT lung densitometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Comparison of low attenuation areas on computed tomographic scans between inner and outer segments of the lung in patients with chronic obstructive pulmonary disease: incidence and contribution to lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The prediction of small airway dimensions using computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

High-resolution computed tomography in healthy smokers and never-smokers: a 6-year follow-up study of men born in 1933.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Centrilobular emphysema: CT-pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The emphysemas: radiologic-pathologic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Thin-section CT in obstructive pulmonary disease: discriminatory value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Centrilobular and Panlobular Emphysema in Smokers: Two Distinct Morphologic and Functional Entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Pathological evaluation of computed tomography images of lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Emphysema: definition, imaging, and quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Pseudophysiologic emphysema resulting from severe small-airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Montelukast improves regional air-trapping due to small airways obstruction in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Quantitative computed tomography detects peripheral airway disease in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

New frontiers in CT imaging of airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Quantitative CT of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Quantitative computed tomography detects air trapping due to asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Morphological progression of emphysema on thin-section CT: Analysis of longitudinal change in the number and size of low-attenuation clusters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Characteristics of COPD phenotypes classified according to the findings of HRCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Discovery of alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Progress in chronic obstructive pulmonary disease genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Genetics of chronic obstructive pulmonary disease, beyond a1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The genetics of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

State of the art. Genetics and genomics of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Functional impairment in emphysema: contribution of airway abnormalities and distribution of parenchymal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Airflow limitation and airway dimensions in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Intrathoracic airway trees: segmentation and airway morphology analysis from low-dose CT scans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

The heme oxygenase system: a regulator of second messenger gases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Possible protective effect against chronic obstructive airways disease by the GC2 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Polymorphisms in the beta2-adrenoreceptor gene are associated with decreased airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

beta(2)-adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Relationship between Extent of Pulmonary Emphysema by High-resolution Computed Tomography and Lung Elastic Recoil in Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Mitochondrial dysfunction in COPD patients with low body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Lung Function Decline and Outcomes in an Adult Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Computed tomography in pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Systemic effects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550701629663

Morphologic and Histochemical Evaluation of Muscle in Patients with Chronic Pulmonary Emphysema Manifesting Generalized Emaciation

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1159/000117421

Identifiers

DOI

10.1080/15412550701629663

1 reference

17 August 2017

1 reference